» Articles » PMID: 37090730

Multiparametric Flow Cytometry to Characterize Vaccine-induced Polyfunctional T Cell Responses and T Cell/NK Cell Exhaustion and Memory Phenotypes in Mouse Immuno-oncology Models

Overview
Journal Front Immunol
Date 2023 Apr 24
PMID 37090730
Authors
Affiliations
Soon will be listed here.
Abstract

Suitable methods to assess immunogenicity and therapeutic efficacy of cancer vaccines in preclinical cancer models are critical to overcome current limitations of cancer vaccines and enhance the clinical applicability of this promising immunotherapeutic strategy. In particular, availability of methods allowing the characterization of T cell responses to endogenous tumor antigens is required to assess vaccine potency and improve the antigen formulation. Moreover, multiparametric assays to deeply characterize tumor-induced and therapy-induced immune modulation are relevant to design mechanism-based combination immunotherapies. Here we describe a versatile multiparametric flow cytometry method to assess the polyfunctionality of tumor antigen-specific CD4 and CD8 T cell responses based on their production of multiple cytokines after short-term restimulation with relevant tumor epitopes of the most common mouse strains. We also report the development and application of two 21-color flow cytometry panels allowing a comprehensive characterization of T cell and natural killer cell exhaustion and memory phenotypes in mice with a particular focus on preclinical cancer models.

Citing Articles

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Raninga P, Zeng B, Moi D, Trethowan E, Saletta F, Venkat P Oncogene. 2024; .

PMID: 39706891 DOI: 10.1038/s41388-024-03259-y.


Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1.

Taylor J, Kokolus K, Basse P, Filderman J, Cosgrove C, Watkins S Vaccines (Basel). 2024; 12(7).

PMID: 39066414 PMC: 11281486. DOI: 10.3390/vaccines12070777.

References
1.
Kallies A, Zehn D, Utzschneider D . Precursor exhausted T cells: key to successful immunotherapy?. Nat Rev Immunol. 2019; 20(2):128-136. DOI: 10.1038/s41577-019-0223-7. View

2.
Li J, He Y, Hao J, Ni L, Dong C . High Levels of Eomes Promote Exhaustion of Anti-tumor CD8 T Cells. Front Immunol. 2019; 9:2981. PMC: 6305494. DOI: 10.3389/fimmu.2018.02981. View

3.
Huang C, Workman C, Flies D, Pan X, Marson A, Zhou G . Role of LAG-3 in regulatory T cells. Immunity. 2004; 21(4):503-13. DOI: 10.1016/j.immuni.2004.08.010. View

4.
Cheng G, Yuan X, Tsai M, Podack E, Yu A, Malek T . IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J Immunol. 2012; 189(4):1780-91. PMC: 3411868. DOI: 10.4049/jimmunol.1103768. View

5.
Shibuya A, Shibuya K . DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses. Int Immunol. 2021; 33(12):687-692. DOI: 10.1093/intimm/dxab085. View